Abstract
Immune reconstitution is an important component of successful allogeneic bone marrow transplantation. Immune reconstitution was evaluated for 5 years after transplantation. While the number of CD8+ T cells and CD56+ cells recovered early post transplantation, a low number of CD4+ and CD4+CD45RA+ T cells and reversal of the CD4/CD8 ratio continued up to 5 years. Although early recovery of IgG and IgM was seen at day 100 post transplantation, serum concentration of IgA was below the normal range at 6 months and increased gradually up to 5 years. Development of acute GVHD did not affect the numbers of CD4+, CD8+, CD4+CD45RA+ and CD4+CD29+ T cells, but the number of CD56+ cells in patients who developed grades II–IV acute GVHD was low. The number of CD4+CD29+ T cells had a tendency to be higher in the patients with extensive chronic GVHD than in those without chronic GVHD 2 years after transplantation whereas the number of CD4+CD45RA+ T cells was low in spite of the absence of chronic GVHD. Serum concentration of IgA was lower in patients with extensive chronic GVHD than in those without chronic GVHD at 180 days. The number of CD4+CD45RA+ cells in 10–19-year-old patients was higher than that in 40–49-year-old patients. Response to the Con A and PHA in 10–19-year-old patients was higher than that in older patients at 1 and 2 years. There was no significant difference in the ability of immune reconstitution between related transplant recipients and unrelated transplant recipients. These results suggest that chronic GVHD and age of patients affected immune reconstitution post transplant. Bone Marrow Transplantation (2001) 27, 1275–1281.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Small TN, Papadopoulos EB, Boulad F et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions Blood 1999 93: 467–480
Dokhelar MC, Wiels J, Lipinski M et al. Natural killer cell activity in human bone marrow recipients. Early reappearance of peripheral natural killer activity in graft-versus-host disease Transplantation 1981 86: 1347–1351
Atkinson K . Reconstruction of the haemopoietic and immune systems after marrow transplantation Bone Marrow Transplant 1990 5: 209–226
Storek J, Witherspoon RP, Storb R . T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life Bone Marrow Transplant 1995 16: 413–425
Atkinson K, Hansen JA, Storb R et al. T cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets Blood 1982 59: 1292–1298
Noel DR, Witherspoon RP, Storb R et al. Does graft-versus-host-disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on long-term survivors Blood 1978 51: 1087–1105
Paulin T, Ringden O, Nilsson B . Immunological recovery after bone marrow transplantation: role of age, graft-versus-host disease, prednisolone treatment and infections Bone Marrow Transplant 1987 1: 317–328
Izutsu KT, Sullivan KM, Schubert MM et al. Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host disease Transplantation 1983 35: 441–446
Small TN, Avigan D, Dupont B et al. Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis Biol Blood Marrow Transplant 1997 3: 65–75
Sao H, Kitaori K, Kato C et al. Study of chronic graft-vs-host disease, infection and immune reconstitution in patients surviving more than one year after bone marrow transplantation from unrelated donors Jpn J Clin Hematol 1999 40: 630–638
Itoh Y, Fukamachi I, Nakajima K et al. A new method for the evaluation of lymphocyte activation by ethidium bromide fluorescence assays Igakunoayumi 1983 126: 21–22
Storek J, Saxon A . Reconstitution of B cell immunity following bone marrow transplantation Bone Marrow Transplant 1992 9: 395–408
Guillaume T, Rubinstein DB, Syman M . Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation Blood 1998 92: 1471–1490
Seddik M, Seemayer TA, Lapp WS . T cell functional defect associated with thymic epithelial injury induced by a graft-versus-host reaction Transplantation 1980 29: 61–66
Seddik M, Seemayer TA, Lapp WS . The graft-versus-host reaction and immune function. I. T helper cell immunodeficiency associated with graft-versus-host induced thymic epithelial cell damage Transplantation 1984 37: 281–286
Witherspoon RP, Deeg HJ, Lum LG et al. Immunologic recovery in human marrow graft recipients given cyclosporine or methotrexate for the prevention of graft-versus-host disease Transplantation 1984 37: 456–461
Witherspoon RP, Matthews D, Storb R et al. Recovery of in vivo cellular immunity after human marrow grafting. Influence of time post grafting and acute graft-versus-host disease Transplantation 1984 37: 145–150
Heitger A, Neu N, Kern H et al. Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation Blood 1997 90: 850–857
Mackall CL, Fleisher TA, Brown MR et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy New Engl J Med 1995 332: 143–149
Kolb H, Sale GE, Lerner KG et al. Pathology of acute GVHD in the dog Am J Pathol 1979 96: 581–594
Keever CA, Small TN, Flomenberg N et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts Blood 1989 73: 1340–1350
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fujimaki, K., Maruta, A., Yoshida, M. et al. Immune reconstitution assessed during five years after allogeneic bone marrow transplantation. Bone Marrow Transplant 27, 1275–1281 (2001). https://doi.org/10.1038/sj.bmt.1703056
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703056
Keywords
This article is cited by
-
The gut microbiome: an important factor influencing therapy for pediatric acute lymphoblastic leukemia
Annals of Hematology (2023)
-
Successful treatment of post chemotherapy esophageal cicatricial atresia in a pediatric patient with anaplastic large cell lymphoma through minimally invasive esophagectomy: a case report
Surgical Case Reports (2021)
-
Lung transplantation for late-onset non-infectious chronic pulmonary complications of allogenic hematopoietic stem cell transplant
Respiratory Research (2021)
-
The risk of malignancies in patients receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis
Clinical and Translational Oncology (2020)
-
Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation
Microbiome (2019)